製品番号: HY-167237

Calactin

Calactin is a glycoside that can be isolated from Asclepias curassavica L.. Calactin activates caspase-3, caspase-8, caspase-9, and phosphorylates ERK. Calactin induces DNA damage, apoptosis, PARP cleavage, G2/M phase cell cycle arrest, shifts Bax/Bcl-2 expression, and shows anti-proliferation effects in leukemia cells. Calactin can be used for the research of leukemia.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 20304-47-6
分子式: C₂₉H₄₀O₉
分子量:532.63

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Calactin 構造式

CAS 番号: 20304-47-6

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- IC₅₀ & Target
- Cellular Effect
- 体外実験
化学情報
純度とドキュメンテーション
参考文献
Calculators
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target^[1]

Caspase-3

Caspase-8

Caspase-9

CDK1/cyclinB1

Bcl-2

Bax

Caspase アイソフォーム固有の製品をすべて表示 :

CDK アイソフォーム固有の製品をすべて表示 :

PARP アイソフォーム固有の製品をすべて表示 :

Bcl-2 Family アイソフォーム固有の製品をすべて表示 :

ERK アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	0.0029 μg/mL Compound: 4	Cytotoxicity against human A549 cells after 3 days by MTT assay Cytotoxicity against human A549 cells after 3 days by MTT assay	[PMID: 16252914]
A549	IC₅₀	0.02 μM Compound: 8	Antiproliferative activity against human A549 cells after 72 hrs by MTT assay Antiproliferative activity against human A549 cells after 72 hrs by MTT assay	[PMID: 19555122]
BC	IC₅₀	2.07 × 10^-5M Compound: 4	Cytotoxicity against human BC cells by SRB assay Cytotoxicity against human BC cells by SRB assay	[PMID: 16933890]
BXPC-3	IC₅₀	0.08 μM Compound: 8	Antiproliferative activity against human BxPC3 cells after 72 hrs by MTT assay Antiproliferative activity against human BxPC3 cells after 72 hrs by MTT assay	[PMID: 19555122]
Calu-1	IC₅₀	0.5 μM Compound: 21	Antiproliferative activity against human Calu1 cells after 72 hrs by MTT assay Antiproliferative activity against human Calu1 cells after 72 hrs by MTT assay	[PMID: 30629433]
HeLa	IC₅₀	0.2 μM Compound: 21	Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay	[PMID: 30629433]
HepG2	IC₅₀	0.02 μg/mL Compound: 4	Cytotoxicity against human HepG2 cells after 3 days by MTT assay Cytotoxicity against human HepG2 cells after 3 days by MTT assay	[PMID: 16252914]
KB	IC₅₀	4.13 × 10^-5M Compound: 4	Cytotoxicity against human KB cells by SRB assay Cytotoxicity against human KB cells by SRB assay	[PMID: 16933890]
LoVo	IC₅₀	0.05 μM Compound: 8	Antiproliferative activity against human LoVo cells after 72 hrs by MTT assay Antiproliferative activity against human LoVo cells after 72 hrs by MTT assay	[PMID: 19555122]
MCF7	IC₅₀	0.01 μg/mL Compound: 4	Cytotoxicity against human MCF7 cells after 3 days by MTT assay Cytotoxicity against human MCF7 cells after 3 days by MTT assay	[PMID: 16252914]
MCF7	IC₅₀	0.04 μM Compound: 8	Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay	[PMID: 19555122]
MCF7	IC₅₀	0.2 μM Compound: 21	Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay	[PMID: 30629433]
MDA-MB-231	IC₅₀	0.03 μg/mL Compound: 4	Cytotoxicity against human MDA-MB-231 cells after 3 days by MTT assay Cytotoxicity against human MDA-MB-231 cells after 3 days by MTT assay	[PMID: 16252914]
NCI-H187	IC₅₀	3.45 × 10^-4M Compound: 4	Cytotoxicity against human NCI-H187 cells by SRB assay Cytotoxicity against human NCI-H187 cells by SRB assay	[PMID: 16933890]
PC-3	IC₅₀	0.02 μM Compound: 8	Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay	[PMID: 19555122]
PC-3	IC₅₀	3.7 μM Compound: 21	Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay	[PMID: 30629433]
U-251	IC₅₀	0.9 μM Compound: 21	Antiproliferative activity against human U251MG cells after 72 hrs by MTT assay Antiproliferative activity against human U251MG cells after 72 hrs by MTT assay	[PMID: 30629433]
U-373MG ATCC	IC₅₀	0.2 μM Compound: 8	Antiproliferative activity against human U373 cells after 72 hrs by MTT assay Antiproliferative activity against human U373 cells after 72 hrs by MTT assay	[PMID: 19555122]

体外実験

Calactin (0.065-1 μM; 0-24 h) exhibits dose-dependent and time-dependent cytotoxicity against human leukemia K562 and Molt-4 cells^[1].
Calactin (0.15 μM; 0-24 h) induces G₂/M phase cell cycle arrest in human leukemia K562 and Molt-4 cells by reducing the expression of Cyclin B1, Cdk1, and Cdc25C^[1].
Calactin (0.15 μM; 0-24 h) induces DNA damage in human leukemia K562 and Molt-4 cells^[1].
Calactin (0.15 μM; 0-24 h) induces apoptosis in human leukemia K562 and Molt-4 cells, and this apoptosis proceeds independently of caspase-3 activity^[1].
Calactin (0.15 μM; 0-24 h) induces apoptosis in human leukemia K562 and Molt-4 cells through both intrinsic and extrinsic apoptotic pathways^[1].
Calactin (0.15 μM; 12 h) upregulates c-Fos mRNA expression in K562 and Molt-4 cells via the ERK signaling pathway^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

human leukemia K562 and Molt-4 cells
Concentration:

0.065, 0.125, 0.15, 0.25, 0.5, 1 μM
Incubation Time:

0, 6, 12, 24 h
Result:

Reduced cell viability in a dose-dependent and time-dependent manner.
Exhibited a LD₅₀of 0.161 μM for K562 cells after 12 h treatment.
Exhibited a LD₅₀of 0.142 μM for Molt-4 cells after 12 h treatment.
Caused progressively decreased cell viability relative to untreated controls when used at 0.15 μM for 6, 12, 18, and 24 h.

Cell Cycle Analysis^[1]

Cell Line:

human leukemia K562 and Molt-4 cells
Concentration:

0.15 μM
Incubation Time:

0, 6, 12, 24 h
Result:

Induced a significant increase in the percentage of K562 cells arrested at the G₂/M phase, from 12.8% at 0 h to 34.4% at 24 h.
Reduced the expression levels of Cyclin B1, Cdk1, and Cdc25C in both cell lines over the 24 h treatment period.

Western Blot Analysis^[1]

Cell Line:

human leukemia K562 and Molt-4 cells
Concentration:

0.15 μM
Incubation Time:

0, 6, 12, 24 h
Result:

Increased phosphorylation levels of Chk2 and H2AX in a time-dependent manner.
Showed no change in total Chk2 or H2AX protein expression.

Apoptosis Analysis^[1]

Cell Line:

human leukemia K562 and Molt-4 cells
Concentration:

0.15 μM
Incubation Time:

0, 6, 12, 24 h
Result:

Caused a significant increase in apoptotic cells after treatment.
Did not block calactin-induced phosphatidylserine exposure when cells were pretreated with Z-DEVD-FMK, indicating no reduction in apoptotic cell levels.

Western Blot Analysis^[1]

Cell Line:

human leukemia K562 and Molt-4 cells
Concentration:

0.15 μM
Incubation Time:

0, 6, 12, 24 h
Result:

Induced PARP cleavage in both cell lines over the 24 h treatment period.
Increased levels of active caspase-3, caspase-8, caspase-9, and Bax in both cell lines over the 24 h treatment period.
Decreased levels of procaspase-3, procaspase-8, procaspase-9, and Bcl-2 in both cell lines over the 24 h treatment period.
Increased phosphorylation levels of ERK and Elk-1 in a time-dependent manner, with no change in total ERK or Elk-1 protein expression.

化学情報

CAS 番号 20304-47-6
分子量 532.63
分子式 C₂₉H₄₀O₉
SMILES

C(=O)[C@@]12[C@@]3([C@]([C@]4(O)[C@](C)(CC3)[C@H](CC4)C5=CC(=O)OC5)(CC[C@]1(C[C@@]6([C@@](C2)(O[C@]7(O)[C@](O6)(O[C@H](C)C[C@H]7O)[H])[H])[H])[H])[H])[H]
Structure Classification
- Terpenoids
- Triterpenes
Initial Source
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Lee CC, et al. The small molecule calactin induces DNA damage and apoptosis in human leukemia cells. Eur J Cancer Prev. 2012;21(5):467-473. [Content Brief]

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

Calactin

Caspase アイソフォーム固有の製品をすべて表示

CDK アイソフォーム固有の製品をすべて表示

PARP アイソフォーム固有の製品をすべて表示

Bcl-2 Family アイソフォーム固有の製品をすべて表示

ERK アイソフォーム固有の製品をすべて表示

生物活性

化学情報

純度とドキュメンテーション

参考文献

Calculators

Help & FAQs

Calactin 関連分類

HY-167237 関連分類